A foreign dihydrofolate reductase gene in transgenic mice acts as a dominant mutation.

AUTOR(ES)

Gordon, J W

RESUMO

We have produced 17 lines of transgenic mice by microinjecting a full-length cDNA clone of an altered dihydrofolate reductase (dhfr) gene. The protein specified by this gene carries a point mutation which triples its Km for dihydrofolate and reduces substrate turnover 20-fold relative to the wild-type enzyme. Transgenic mice from different pedigrees, several of which carry a single copy of this gene in different integration sites, manifest an array of similar developmental abnormalities including growth stunting, reduced fertility, pigmentation changes, and skeletal defects. These defects appear in animals heterozygous for the foreign gene. RNA analyses demonstrate significant expression of the cDNA in newborn mice and adult tissues. These findings show that the additional dhfr gene exerts its mutational effects in a dominant fashion, and therefore the data indicate that transgenic mice can serve as models for elucidating mechanisms of dominant mutagenesis.

Documentos Relacionados

• Systemic resistance to methotrexate in transgenic mice carrying a mutant dihydrofolate reductase gene.
• Methotrexate resistance in an in vivo mouse tumor due to a non-active-site dihydrofolate reductase mutation.
• Single-headed myosin II acts as a dominant negative mutation in Dictyostelium.
• The int-2 gene product acts as an epithelial growth factor in transgenic mice.
• Limbic epilepsy in transgenic mice carrying a Ca2+/calmodulin-dependent kinase II alpha-subunit mutation.